← All Cases

FDA v. Wages and White Lion Investments, L.L.C.

No. 23-1038 SCOTUS · Decided Decided SCOTUS
Cert Granted: Jul 2, 2024 Argued: Dec 2, 2024 Decided: Apr 2, 2025
📄 Read the Opinion

Case Overview

Wages and White Lion Investments challenged the FDA's denial of its premarket tobacco product applications for flavored e-cigarettes, arguing the agency applied different standards than it had communicated. The Supreme Court reversed the Fifth Circuit and held unanimously that the FDA's denials were not arbitrary and capricious under the APA, because the agency had applied consistent public-health criteria throughout its review process.


The Facts

Wages and White Lion submitted applications under the Family Smoking Prevention and Tobacco Control Act for flavored e-cigarette products. The FDA denied the applications, finding insufficient evidence that the products' benefits to adult smokers outweighed the risk of youth initiation. The Fifth Circuit vacated the denials, concluding the FDA had shifted its standards between its guidance documents and the actual review. The Supreme Court reversed.

The Application

History

The applicants claimed the FDA had communicated one set of evaluation standards in guidance but applied different standards during its actual review of the flavored e-cigarette applications. The Court examined the regulatory record and found that the FDA had consistently applied public-health criteria—specifically, whether the products' benefits to adult smokers outweighed risks to youth—from its initial guidance through its final denials of Wages and White Lion's applications. Because the agency had maintained consistency between its stated approach and its actual decision-making, and had explained its reasoning with reference to scientific evidence, the Court concluded the FDA had not acted arbitrarily and capriciously under the APA.

The Conclusion

**Wages and White Lion reaffirms that FDA's premarket tobacco review survives APA scrutiny when the agency applies scientifically supported criteria consistently communicated in prior guidance.** The ruling reinstates FDA's authority to deny flavored e-cigarette applications on population-level public health grounds and confirms that courts may not substitute their scientific judgments for the agency's where the agency has explained its reasoning adequately.

CourtSupreme Court of the United States
FiledDec 21, 2023
Judge
CL Statusactive
View on CourtListener →

No circuit court data for this case.

Cert GrantedJul 2, 2024
Statusactive
Filed (CL)Dec 21, 2023
View on CourtListener →
Subscribe on Substack ↗

This tracker is maintained by BrynoDC and is free because readers fund it. Support